Get started
Author

James Millard

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 533
PDF
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
2022 · Timothy M Walker, Paolo Miotto, et al. · The Lancet Microbe · 277
PDF
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
2017 · Guy E Thwaites, Matthew Scarborough, et al. · The Lancet · 199
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129
Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis
2020 · Camus Nimmo, James Millard, et al. · The Lancet Microbe · 110
PDF
Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis
2023 · Lindsay Sonnenkalb, Joshua James Carter, et al. · The Lancet Microbe · 104
PDF
Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients
2020 · Camus Nimmo, James Millard, et al. · European Respiratory Journal · 88
PDF
Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment
2020 · Camus Nimmo, Kayleen Brien, et al. · EBioMedicine · 87
PDF
Multidrug resistant tuberculosis
2015 · J. Millard, C. Ugarte-Gil, et al. · BMJ · 73
PDF
Evolution of Mycobacterium tuberculosis drug resistance in the genomic era
2022 · Camus Nimmo, James Millard, et al. · Frontiers in Cellular and Infection Microbiology · 61
PDF
Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach
2024 · Ivan Barilar, Simone Battaglia, et al. · Nature Communications · 55
PDF
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
2022 · Viola Dreyer, Ayan Mandal, et al. · Genome Medicine · 47
PDF
Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and Lumefantrine
2023 · Donelly A van Schalkwyk, Sade Pratt, et al. · Clinical Infectious Diseases · 42
PDF
Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation
2018 · James Millard, Henry Pertinez, et al. · Journal of Antimicrobial Chemotherapy · 42
PDF
QT Interval Prolongation in People Treated With Bedaquiline for Drug-Resistant Tuberculosis Under Programmatic Conditions: A Retrospective Cohort Study
2021 · Sharon Isralls, Kathy Baisley, et al. · Open Forum Infectious Diseases · 38
PDF
N -Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and N -Acetyl-Isoniazid Pharmacokinetics during Antituberculosis Treatment
2020 · Thuli Mthiyane, James Millard, et al. · Antimicrobial Agents and Chemotherapy · 31
Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB
2023 · James Millard, Stephanie Rimmer, et al. · Emerging infectious diseases · 22
Detection of a historic reservoir of bedaquiline/clofazimine resistance-associated variants in Mycobacterium tuberculosis
2024 · Camus Nimmo, Arturo Torres Ortiz, et al. · Genome Medicine · 21
PDF
Understanding of research, genetics and genetic research in a rapid ethical assessment in north west Cameroon
2015 · Jonas A. Kengne-Ouafo, James D. Millard, et al. · International Health · 15
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12
PDF
Assessing the external validity of a randomized controlled trial of anthelminthics in mothers and their children in Entebbe, Uganda
2014 · James D Millard, Lawrence Muhangi, et al. · Trials · 11
PDF
Mesenchymal hamartoma of the liver: is biopsy always necessary?
2006 · J. Millard, N. Fraser, et al. · Pediatric Surgery International · 11
The impact of inclusion, dose and duration of pyrazinamide (PZA) on efficacy and safety outcomes in tuberculosis: systematic review and meta-analysis protocol
2019 · James D. Millard, Elizabeth A. Mackay, et al. · Systematic Reviews · 6
PDF
Works count: 46
Citation count: 2,717
H-index: 19
I10-index: 24
Year
Topic
Type